Impact of COVID-19 on initiation of biologic therapy prescriptions for chronic inflammatory diseases

Joint Bone Spine. 2022 Jan;89(1):105253. doi: 10.1016/j.jbspin.2021.105253. Epub 2021 Jul 24.
No abstract available

Keywords: Biologics; COVID-19; Treatment.

Publication types

  • Letter

MeSH terms

  • Biological Products* / therapeutic use
  • Biological Therapy
  • COVID-19*
  • Humans
  • Prescriptions
  • SARS-CoV-2

Substances

  • Biological Products